FOR SECURITY PURPOSES - because Internet Explorer is no longer supported by Microsoft, we suggest that you interact with our secure site through one of our supported browsers - Google Chrome, Firefox, or MS Edge. If you continue to use this website with Internet Explorer you do so at your own risk and you may encounter problems.
Reference Analysis of Active Ingredients Betamethasone, Clotrimazole, and Gentamicin from a Topical Cream Formulation using a Kinetex 2.6 µm Polar C18 HPLC/UHPLC Column
The active ingredients gentamicin, clotrimazole, and betamethasone are drug substances which can be formulated into topically administered creams. In this application, we investigated a reversed phase method that leveraged the dual selectivity of the Kinetex Polar C18 because of the differences in polarity and hydrophobicity between these three compounds.
Reference Analysis of Active Ingredients Betamethasone, Clotrimazole, and Gentamicin from a Topical Cream Formulation using a Kinetex 2.6 µm Polar C18 HPLC/UHPLC Column
The active ingredients gentamicin, clotrimazole, and betamethasone are drug substances which can be formulated into topically administered creams. In this application, we investigated a reversed phase method that leveraged the dual selectivity of the Kinetex Polar C18 because of the differences in polarity and hydrophobicity between these three compounds.
Reference Analysis of Active Ingredients Betamethasone, Clotrimazole, and Gentamicin from a Topical Cream Formulation using a Kinetex 2.6 µm Polar C18 HPLC/UHPLC Column
The active ingredients gentamicin, clotrimazole, and betamethasone are drug substances which can be formulated into topically administered creams. In this application, we investigated a reversed phase method that leveraged the dual selectivity of the Kinetex Polar C18 because of the differences in polarity and hydrophobicity between these three compounds.